Pediapharm to Register, Market and Sell in Canada. Denver, CO and Montreal, QC -- February 25, 2009 -- Ceragenix Pharmaceuticals, Inc.("Ceragenix") (OTCBB:CGXP), a medical device company focused on ...

DENVER Dr. Reddy’s Laboratories has inked an exclusive distribution and supply agreement with the biotech company Ceragenix Pharmaceuticals to commercialize EpiCeram, a topical cream used for treating ...

This is the first milestone granted in $3.5M deal to commercialize nonsteroidal skincare cream. Ceragenix Pharmaceuticals received a $1.5 million milestone payment from Dr. Reddy’s Laboratories ...

Ceragenix Pharmaceuticals Inc. said Monday it's begun enrolling patients in a pediatric clinical study to assess the effectiveness of its cream to treat eczema. The Denver company (OTCBB: CGXP) ...

April 18, 2006 — The US Food and Drug Administration (FDA) has approved an integrated insulin pump and continuous glucose monitoring system for the management of type 1 and type 2 diabetes mellitus; 3 ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

This was a non-controlled (all participants treated), open label (parents of participants and study staff all knew the treatment status of all children), phase 1 study. The trial was registered with ...

DENVER Ceragenix Pharmaceuticals has received a $1.5 million milestone payment from Dr. Reddy’s Laboratories due to the commercialization of the eczema cream EpiCeram in the U.S. The agreement between ...